Position PaperThe importance of early symptom recognition in the context of early detection and cancer survival
Introduction
Cancers comprise a major part of the global chronic disease burden and increasingly contribute to the mortality in low and middle income countries (LMICs).1 Projections indicate that demographic changes and population growth will result in an increase in cancer deaths from 7.1 million in 2002 to 11.5 million in 2030.2 Worldwide, about one third of all cancers are estimated to be amenable to early detection and potential cure with treatment. Raising awareness in the general population about early symptoms is part of a comprehensive approach to control cancer.3
A large number of cancer patients could be saved from premature death and suffering if they had timely access to early detection programmes and to adequate treatment. In addition to socio-demographic variables such as age and socio-economic status (SES), cancer survival is determined by the availability of health education about cancer symptoms to the public and health care professionals, especially those working in primary care, and the access to appropriate diagnostic tests and effective treatment. Early diagnosis can arise from recognition of symptomatic cancers at an earlier stage, when the cancer is localised to the organ of origin and before it invades the surrounding tissue and thus has a higher potential for cure. Early diagnosis is made in symptomatic patients who can detect the symptoms on their own or by health professionals, e.g. in primary care settings. Organised screening programmes, on the other hand, are aimed at detecting tumours through screening asymptomatic individuals and are defined as a site-specific search for malignancies at a stage prior to that detectable by the patient.4 Currently, screening programmes are recommended for cancers of the breast and cervix.3 Since screening is applied to a presumably asymptomatic population, it is not considered further here.
The main challenge for early diagnosis programmes is the sensitivity and specificity of signs and symptoms. The wide variation of first alarm symptoms has been shown in a study on malignancies of the upper gastrointestinal tract.5 Many types of cancers show no specific symptoms at an early stage and are thus diagnosed at a more advanced disease stage. Colorectal cancer symptoms, for example, can be vague and confused with normal fluctuations in bowel habits experienced by the general population.6, 7, 8 Also, head and neck squamous cell carcinomas present with nonspecific symptoms such as sore throat and neck nodes which are shared with common conditions, namely viral pharyngitis or tonsillitis.9
Section snippets
Early cancer diagnosis and survival
A delay in diagnosis with cancer being detected at a more advanced stage is a negative factor in cancer prognosis. For most cancer types, stage at diagnosis is identified to be one of the most important determinants for patient survival.10, 11, 12 Earlier stage has been linked to better survival of selected cancers such as cancers of the breast,13, 14, 15, 16, 17 cervix,18 lung,14, 15 stomach,15, 19 prostate,20, 21 liver,22 and urinary bladder.14, 23 Differences in melanoma skin cancer survival
Review of clinical definitions for earlier and later signs and symptoms
Although there is an official staging system classifying early and advanced cancer stage,34 the terminology of early and advanced with regard to cancer signs and symptoms is not precise and is used differently by health care providers and in different countries. The manifestation of symptoms listed as suitable for early diagnosis greatly depends on location and nature of the tumour and some are only manifested at an advanced stage of the disease.3
There are few definitions from medical textbooks
Impact of awareness intervention on cancer outcome
Education of the public and health care providers on early cancer signs is part of the early detection approach but there have been few investigations on the impact of awareness campaigns on cancer outcomes. The assessment of a newspaper campaign to raise awareness of faecal blood as a possible sign of colorectal cancer indicated that the campaign would lead to more detection of early colorectal cancer cases since there were a number of neglected faecal bleeders in the population.42 A prostate
Discussion
Early cancer detection is a key part of national comprehensive cancer control and can be promoted in every country.56 However, several considerations have to be taken into account in promoting early cancer diagnosis and there are some limitations to this approach.
First, the effect of early diagnosis is mediated by the stage of disease when definite diagnosis is made and treatment is provided. Early detection may thus be effective due to its association with a limited spread of the tumour at
Conclusion
A reduction in cancer deaths is a health care priority and efforts in down-staging cancer can significantly increase cancer survival for many cancer sites such as of the breast, cervix, skin, oral, prostate, and possibly of the lung, stomach, liver and bladder. However, generally low attention is paid to early diagnosis or the need for cultural-sensitive approaches to early cancer detection which take country-specific priorities, socio-economic differences and the health system context into
Conflict of interest statement
None declared.
References (57)
- et al.
Limited value of alarm features in the diagnosis of upper gastrointestinal malignancy: systematic review and meta-analysis
Gastroenterology
(2006) - et al.
Symptoms of carcinoma of the colon and rectum
Lancet
(1968) - et al.
Delay of treatment is associated with advanced stage of rectal cancer but not of colon cancer
Cancer Detect Prev
(2006) - et al.
Cancer survival and the duration of symptoms. An analysis of possible forms of the risk function
Eur J Cancer
(1994) - et al.
Influence of delay on survival in patients with breast cancer: a systematic review
Lancet
(1999) - et al.
Tumor size is of prognostic value in surgically treated FIGO stage II cervical cancer
Gynecol Oncol
(2007) - et al.
Long-term prognosis of gastric cancer in a European country: a population-based study in Florence (Italy). 10-year survival of cases diagnosed in 1985–1987
Eur J Cancer
(2001) - et al.
Overall survival in the intervention arm of a randomized controlled screening trial for prostate cancer compared with a clinically diagnosed cohort
Eur Urol
(2008) - et al.
The efficacy of treatment schedules according to Barcelona Clinic Liver Cancer staging for hepatocellular carcinoma – survival analysis of 3892 patients
Eur J Cancer
(2008) - et al.
Survival after diagnosis of cancer of the oral cavity
Br J Oral Maxillofac Surg
(2008)
Staging and survival of colorectal cancer: are we making progress? The 14-year experience of a specialized cancer registry
Dig Liver Dis
Lack of association between diagnostic and therapeutic delay and stage of colorectal cancer
Eur J Cancer
The effects of an awareness-raising program for patients and primary care physicians on the early detection of gastro-oesophageal cancer
Surgery
Why is breast cancer mortality declining?
Lancet Oncol
Preventing cancer through tobacco and infection control: how many lives can we save in the next 10 years?
Eur J Cancer Prev
Projections of global mortality and burden of disease from 2002 to 2030
PLoS Med
Cancer control. Knowledge into action. WHO Guide for effective programmes: early detection
Cancer symptoms, clinical stage, and survival rates
Am J Public Health
Comparison of gastrointestinal symptoms in colorectal carcinoma patients and community controls with respect to age
Gut
Delay in referral of oropharyngeal squamous cell carcinoma to secondary care correlates with a more advanced stage at presentation, and is associated with poorer survival
Br J Cancer
Strategies for global control of cervical cancer
Int J Cancer
General practitioners and cancer: primary care oncology needs more research if it is to develop
BMJ
Cancer patient survival – patterns, comparisons, trends – a population-based Cancer Registry study in Finland
Acta Oncol
Henson. Relation of tumour size, lymph node status, and survival in 24, 740 breast cancer cases
Cancer
Influence of “diagnostic delay” upon cancer survival: an analysis of five tumour sites
J Epidemiol Community Health
Stage at diagnosis is a key explanation of differences in breast cancer survival across Europe
Int J Cancer
Interpreting recent trends in prostate cancer incidence and mortality
Epidemiology
Bladder carcinoma. Long-term survival and late recurrence
Scand J Urol Nephrol
Cited by (67)
Development and validation of the cervical cancer knowledge scale and HPV testing knowledge scale in a sample of Canadian women
2022, Preventive Medicine ReportsCitation Excerpt :Knowledge of cervical cancer and HPV testing varies and is associated with sufficient screening for cervical cancer (Tatar et al., 2020; Kasting et al., 2017). In low-income countries, which have the highest incidence of cervical cancer, low knowledge about cervical cancer is an additional barrier to screening, help-seeking, and subsequent early detection of cervical cancer beyond the limited access to screening resources (Getachew et al., 2019; Getahun et al., 2013; Mwaka et al., 2013; Ott et al., 2009; Kangmennaang et al., 2018; Islam et al., 2017; Chidyaonga-Maseko et al., 2015). In high-income countries like Canada, where screening is widespread and often administered through organized programs, knowledge is generally high.
Gender differential in the pattern and severity of perceived symptoms among diabetes patients in India
2024, Diabetology InternationalDysregulated expression of piRNAs serve as diagnostic markers in cancers: a systematic review and meta-analysis
2024, Chinese Journal of Evidence-Based MedicineFactor associated with willingness to pay for prevention of cancer: a study of prostate cancer screening
2023, Cost Effectiveness and Resource Allocation